StockData
Cresco Labs Inc. logo

Cresco Labs Inc. (CRLBF) stock

CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 6, 2026Score 4/30
$0.58−0.02 (-3.13%)

Close on Oct 19, 2026Market cap –P/E –Yield –

How the market prices Cresco Labs

Each ratio against its own distribution since 2020, from month-end prices and the figures reported at the time

Cresco Labs trades at 0.3× its earnings, against a median of 0.5× since 2020 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2020, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2020

Median 0.5×, today 0.3×

What Cresco Labs keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin49.5%vs 52.8%
Operating margin-4.27%vs -42.9%
EBITDA margin3.16%vs -29.3%
Pretax margin-14.5%vs -13.0%
Net margin-20.6%vs -39.9%
Free cash flow margin5.76%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-33.2%vs -53.5%
Return on assets-10.6%vs -40.7%
Return on invested capital-2.90%vs -32.4%
Return on capital employed-2.55%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.51vs 0.39
Inventory turns a year3.64vs 2.68

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $373.28M, or 18.0 times a year of EBITDA.

Total debt$431.18M
Cash and short-term investments$57.90M
EBITDA, trailing twelve months$20.73M
Free cash flow, trailing twelve months$37.75M

Leverage and liquidity

Debt to equity1.27vs 0.50
Debt to EBITDA20.80vs 3.42
Net debt to EBITDA18.01vs 2.33
Debt to free cash flow11.42vs 4.83
Current ratio2.59vs 3.30
Quick ratio0.96vs 2.38

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

2 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-3.59
No flagManipulation risk

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

CRLBFS&P 500
PeriodCRLBFS&P 500DifferenceCRLBF per yearS&P 500 per year
1 month-23.2%+0.6%−23.8 pts
3 months-23.2%+3.4%−26.6 pts
Year to date-53.2%+13.3%−66.5 pts
1 year-52.8%+16.6%−69.4 pts
3 years-65.3%+86.4%−151.6 pts-29.7%+23.1%
5 years-93.2%+81.9%−175.0 pts-41.5%+12.7%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CRLBF shares were sold short on Oct 30, 2026, down 21.9% from the previous report. At recent volumes it would take 1.4 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,084,769-21.9%784,4521.4
Oct 15, 20261,388,290+29.6%1,060,4241.3
Sep 30, 20261,071,011+5.5%1,781,2501.0
Sep 15, 20261,015,351-12.0%883,3691.1
Aug 31, 20261,153,448-18.7%850,6901.4
Aug 14, 20261,418,054+26.1%625,7252.3
Jul 31, 20261,124,815+33.5%852,2121.3
Jul 15, 2026842,750-1.1%827,5281.0
Jun 30, 2026851,967-7.5%907,8331.0
Jun 15, 2026920,777+28.6%1,300,7731.0
May 29, 2026715,974-15.7%1,077,6291.0
May 15, 2026848,963+10.0%1,754,4871.0

Every measure, in full

51 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
2.76%
10.9%
Float
503M
49M
Shares Held by Insiders
0.00%
11.2%
Shares Held by Institutions
0.03%
56.2%

MarginsIndustry

Gross Margin
49.5%
52.8%
Operating Margin
-4.27%
-42.9%
Pretax Margin
-14.5%
-13.0%
Profit Margin
-20.6%
-39.9%
EBITDA Margin
3.16%
-29.3%
FCF Margin
5.76%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
-33.2%
-53.5%
Return on Assets (ROA)
-10.6%
-40.7%
Return on Invested Capital (ROIC)
-2.90%
-32.4%
Return on Capital Employed (ROCE)
-2.55%
-38.7%

Financial positionIndustry

Current Ratio
2.59
3.30
Quick Ratio
0.96
2.38
Debt / Equity
1.27
0.50
Debt / EBITDA
20.80
3.42
Debt / FCF
11.42
4.83
Net Debt / EBITDA
18.01
2.33
Interest Coverage
-0.67
-6.20

GrowthIndustry

Revenue Growth (YoY)
-9.46%
5.71%
FCF Growth (YoY)
-66.6%
3.26%
Revenue Growth (3Y CAGR)
-8.02%
2.25%
Revenue Growth (5Y CAGR)
6.61%
6.41%

EfficiencyIndustry

Asset Turnover
0.51
0.39
Inventory Turnover
3.64
2.68

Income statement (TTM)Industry

Revenue
$655.85M
$58.79M
Gross Profit
$324.57M
$103.58M
Operating Income
-$27.99M
-$21.49M
Pretax Income
-$95.42M
-$14.83M
Net Income
-$135.41M
-$22.47M
EBITDA
$20.73M
-$17.14M
EPS (Diluted)
-$0.38
-$0.83

Balance sheetIndustry

Total Debt
$431.18M
$114.91M
Net Cash (Debt)
-$373.28M
$15.35M
Net Cash Per Share
-$0.74
$0.71
Equity (Book Value)
$340.45M
$49.84M
Book Value Per Share
$0.68
$1.45
Tangible Book Value
-$143.07M
$23.91M
Working Capital
$159.09M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$72.89M
-$12.17M
Capital Expenditures
-$35.14M
-$1.03M
Free Cash Flow
$37.75M
-$20.28M
FCF Per Share
$0.08
-$0.42

Taxes and interestIndustry

Interest Expense
$41.75M
$3.07M
Income Tax
$44.62M
$80.43K

Scores and fair valueIndustry

Piotroski F-Score
2
4
Beneish M-Score
-3.59
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?